Porous nanofibrous microspheres show promise for diabetic wound treatment

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary injectable granular filler that could transform the way diabetic wounds are treated, potentially improving patient outcomes. The study, published in ACS Nano, introduced an innovative approach using specialized porous dermal fillers that accelerate tissue healing and regeneration.